Aberrant overexpression of vascular endothelial growth factor in pancreatic ductal adenocarcinoma is associated with aggressive clinical behavior
Naomi Y Jiang1, Bruce A Woda2, Liping Zhang2, Suyang Hao2, Karen A Dresser2, Di Lu21Massachusetts Institute of Technology, Worcester, MA, USA; 2Department of Pathology, University of Massachusetts Medical Center, Worcester, MA, USAAbstract: Pancreatic adenocarcinoma is a leading cause of cancer-rela...
Main Authors: | Naomi Y Jiang, Bruce A Woda, Liping Zhang, et al |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2010-07-01
|
Series: | Pathology and Laboratory Medicine International |
Online Access: | http://www.dovepress.com/aberrant-overexpression-of-vascular-endothelial-growth-factor-in-pancr-a4833 |
Similar Items
-
Combined Analysis of the Aberrant Epigenetic Alteration of Pancreatic Ductal Adenocarcinoma
by: Rui Xu, et al.
Published: (2019-01-01) -
ADAM9 contributes to vascular invasion in pancreatic ductal adenocarcinoma
by: Victor O. Oria, et al.
Published: (2019-02-01) -
miRNA-1290 Promotes Aggressiveness in Pancreatic Ductal Adenocarcinoma by Targeting IKK1
by: Na Ta, et al.
Published: (2018-11-01) -
Vascularization, Oxygenation, and the Effect of Sunitinib Treatment in Pancreatic Ductal Adenocarcinoma Xenografts
by: Jon-Vidar Gaustad, et al.
Published: (2019-08-01) -
Syndecans and Pancreatic Ductal Adenocarcinoma
by: Nausika Betriu, et al.
Published: (2021-02-01)